2-[4-[[4-[1-cyclopropyl-3-[(2-fluoroanilino)methyl]pyrazol-4-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol
C26H27FN6O2 — CID 155450796
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[4-[[4-[1-cyclopropyl-3-[(2-fluoroanilino)methyl]pyrazol-4-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol
2-[4-[[4-[1-cyclopropyl-3-[(2-fluoroanilino)methyl]pyrazol-4-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol (PubChem CID 155450796) has the molecular formula C26H27FN6O2 and a molecular weight of 474.54 g/mol. Its IUPAC name is 2-[4-[[4-[1-cyclopropyl-3-[(2-fluoroanilino)methyl]pyrazol-4-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol.
Molecular Properties
| Compound Name | 2-[4-[[4-[1-cyclopropyl-3-[(2-fluoroanilino)methyl]pyrazol-4-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol |
|---|---|
| PubChem CID | 155450796 |
| Molecular Formula | C26H27FN6O2 |
| Molecular Weight | 474.54 g/mol |
| Exact Mass | 474.22 |
| IUPAC Name | 2-[4-[[4-[1-cyclopropyl-3-[(2-fluoroanilino)methyl]pyrazol-4-yl]oxy-2-pyridinyl]amino]-2-pyridinyl]propan-2-ol |
| SMILES | CC(C)(O)c1cc(Nc2cc(Oc3cn(C4CC4)nc3CNc3ccccc3F)ccn2)ccn1 |
| InChI | InChI=1S/C26H27FN6O2/c1-26(2,34)24-13-17(9-11-28-24)31-25-14-19(10-12-29-25)35-23-16-33(18-7-8-18)32-22(23)15-30-21-6-4-3-5-20(21)27/h3-6,9-14,16,18,30,34H,7-8,15H2,1-2H3,(H,28,29,31) |
| InChIKey | GPLVKOVIJDWNBM-UHFFFAOYSA-N |
| XLogP | 5.52 |
| TPSA | 97.12 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 474.54 |
| LogP ≤ 5 | 5.52 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155450796 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.